Sputnik V: Proven Vaccine, Political Ploy, or Both?

In August 2020, Russia became the first country to approve a COVID-19 vaccine, Sputnik V, despite global skepticism due to its rapid development and lack of phase three trial data. The vaccine's development was based on previous research for MERS and Ebola. Despite initial doubts, scientific validation in The Lancet confirmed its efficacy, leading to increased demand. Sputnik V uses adenovirus vector technology, making it stable and affordable for developing countries. However, production challenges and political implications affect its global distribution. Russia's vaccine efforts have improved its international image, despite domestic hesitancy.

What role did the Gamelay Research Institute play in the development of the vaccine?

What factors contributed to the skepticism surrounding the Sputnik V vaccine?

What were the advantages of the Sputnik V vaccine compared to mRNA vaccines?

How did the Russian government use the vaccine as a tool of soft diplomacy?